---
title: SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs
date: '2024-10-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39412366/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241016183241&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Class III antiarrhythmic drugs are potential inhibitors
  of ORF 3a-mediated currents, offering new options for the treatment of COVID-19-related
  cardiac ...'
disable_comments: true
---
CONCLUSION: Class III antiarrhythmic drugs are potential inhibitors of ORF 3a-mediated currents, offering new options for the treatment of COVID-19-related cardiac ...